Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gamida Cell Ltd
(NQ:
GMDA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Gamida Cell Ltd
< Previous
1
2
3
Next >
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
April 01, 2024
Appoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of Directors
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
October 16, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Issues Update on Israel Operations
October 09, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa
October 02, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
September 28, 2023
From
Gamida Cell Ltd.
Via
Business Wire
First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv)
September 27, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference
August 31, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
August 14, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Report Second Quarter 2023 Financial Results
August 01, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell’s Omisirge® (omidubicel-onlv)
July 11, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference
May 31, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting
May 31, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Appoints Terry Coelho as CFO
May 22, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update
May 15, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast
May 11, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Pricing of $23 Million Public Offering of Securities
April 19, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Launch of Public Offering of Securities
April 18, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Stock Jumps Over 100% on FDA Approval
April 18, 2023
Gamida Cell Ltd. (NASDAQ: GMDA) is an Israeli-based developmental biotechnology company specializing in discovering and advancing cell therapies to fight bloo
Via
MarketBeat
Exposures
Product Safety
Gamida Cell (NASDAQ: GMDA) Announces its Omisirge Allogeneic Cell Therapy Receives FDA Approval
April 18, 2023
Gamida Cell Ltd. (NASDAQ: GMDA) is a biopharma company that is focused on utilizing cell therapy to create innovative therapeutics.
Via
Spotlight Growth
Exposures
Product Safety
Promising Upsides on these Biotech Penny Stocks
April 18, 2023
These three biotech stocks each have a consensus Buy rating. While they are down from historic highs, impressive upsides make them worth consideration.
Via
MarketBeat
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
April 17, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update
March 27, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Changes to Board of Directors
March 20, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast
March 20, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR
February 18, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Closing of $25 Million Financing With Highbridge
December 12, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences
November 23, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Provides Regulatory Update on Omidubicel
November 21, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update
November 14, 2022
From
Gamida Cell Ltd.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.